Depressive Disorders - China

  • China
  • Revenue in the Depressive Disorders market is projected to reach US$1.91bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 1.66%, resulting in a market volume of US$2.04bn by 2028.
  • In global comparison, most revenue will be generated in the United States (US$6,263.00m in 2024).
  • In relation to total population figures, per person revenues of US$45.36 are generated in 2024.

Key regions: Japan, United Kingdom, China, Europe, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Depressive Disorders market in China has been experiencing significant growth in recent years. Customer preferences for mental health treatment have shifted towards seeking professional help and utilizing medication. This trend is driven by several factors, including increased awareness and understanding of mental health issues, changing societal attitudes towards mental health, and the availability of more treatment options.

Customer preferences:
In the past, mental health issues were often stigmatized in Chinese society, leading many individuals to suffer in silence. However, there has been a notable shift in customer preferences, with more people now seeking professional help for depressive disorders. This change can be attributed to increased awareness and understanding of mental health issues, as well as a growing acceptance of seeking treatment. Customers are also increasingly open to using medication as part of their treatment plan, recognizing the benefits it can provide in managing depressive disorders.

Trends in the market:
One of the key trends in the Depressive Disorders market in China is the growing demand for antidepressant medications. As more people seek professional help and are diagnosed with depressive disorders, the need for medication to manage symptoms has increased. This trend is also influenced by the availability of a wider range of antidepressant medications in the market, providing customers with more options to choose from.Another trend in the market is the rise of online mental health platforms and telemedicine services. These platforms provide convenient and accessible ways for individuals to seek professional help for their depressive disorders. With the increasing use of smartphones and internet connectivity in China, online mental health platforms have become popular among customers who prefer the convenience and privacy they offer.

Local special circumstances:
China's large population and rapid urbanization have contributed to the growth of the Depressive Disorders market. The fast-paced and competitive nature of urban life, coupled with the pressure to succeed, has led to an increase in mental health issues among the population. This has created a significant market opportunity for mental health professionals and pharmaceutical companies to meet the growing demand for treatment.

Underlying macroeconomic factors:
China's economic growth and rising disposable incomes have also played a role in the development of the Depressive Disorders market. As people become more financially stable, they are more willing to invest in their mental health and seek professional treatment. Additionally, the government's increased focus on mental health and the inclusion of mental health services in public healthcare coverage have further contributed to the growth of the market.In conclusion, the Depressive Disorders market in China is experiencing growth due to changing customer preferences, increased awareness of mental health issues, and the availability of more treatment options. The demand for antidepressant medications and online mental health platforms is on the rise, driven by a growing acceptance of seeking professional help and the convenience they offer. China's large population, rapid urbanization, and improving economic conditions have created a favorable environment for the development of the market.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Patients
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)